Cineplex: Canaccord Reiterates $7.00 Target, Upgrades To Hold

Cineplex Inc (TSX: CGX) reported their third quarter results on Friday, reporting revenues of $61 million, a significant decline from the $418.4 million reported in the year ago period. In terms of loss per share, the company incurred a loss of $1.91 for each share outstanding. Naturally, the loss is largely a function of the ongoing pandemic, with the company announcing Friday that they had managed to secure financial covenant suspensions on their outstanding credit facilities, which currently total $460 million, with the suspensions being extended until the second quarter of 2021.

This morning, Canaccord Genuity reiterated their 12-month price target of C$7.00 and upgraded the stock to hold from sell. Aravinda Galappatthige, Canaccord’s analyst, expects Cineplex not to meet its financial covenants that were extended to the second quarter of 2021. She says, “it is reasonable to believe that the banking syndicate will offer a further extension on the back of the aforementioned mitigating initiatives. Factoring in the above, we upgrade the stock to HOLD from Sell.”

Galappatthige makes a note of the recent uptick in COVID cases in Canada and expects that this will cause further delays in a recovery. She comments, “we felt that management formulated a formidable combination of developments to strengthen its balance sheet and financial picture.”

Galappatthige has made slight adjustments to their 2020 and 2021 estimates, decreasing expected revenues from $509.4 million and $1,100.4 million to $491.4 million and $1,086.9 million, respectively. EBITDA meanwhile is expected to improve from -$163.8 million to -$115.5 million in 2020, and increase from $79.5 million to $119.0 million in 2021 based on the revised estimates.

She then says, “There is still a fair bit of uncertainty around central factors like film slates, and the eventual shape of the box office recovery.” Galappatthige turns to China and Japan, saying that their data suggests a quick return as conditions ease but then presents a different point of view citing, “extended periods of closures can have an impact on consumer behavior patterns, and potentially trigger increased direct releases.”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why This War Made the Gold Case Stronger | Michael Gentile

Wall Street Bought the Ceasefire. Now Oil’s Back Over $100 | Todd Bubba Horwitz

Canada’s Soft Spot: Why Every Canadian Manufacturer Should Be Watching the July 1st CUSMA Negotiation

Recommended

Total Metals Secures High Grade Critical Minerals Property In Northwestern Ontario

Discovery at Luis Hill Prompts Acceleration of Phase 2 Program for Questcorp

Related News

Ayr Wellness Sees Canaccord Cut Target To $30 Following Q2 Miss

On August 18, Ayr Wellness (CSE: AYR.A)s reported its second quarter financial results. The company...

Sunday, September 4, 2022, 03:01:00 PM

Uranium Royalty Corp: Canaccord Lifts Price Target To $4.25

Uranium Royalty Corp (TSXV: URC) recently closed their C$37 million financing, allowing Canaccord Genuity to...

Saturday, May 22, 2021, 02:04:00 PM

Ayr Wellness: Canaccord Reiterates $70 Price Target Following Earnings

Earlier this week, Ayr Wellness (CSE: AYR.a) reported their first-quarter earnings. The company reported revenues...

Friday, May 28, 2021, 04:02:00 PM

Curaleaf: The Analyst Take On The European Expansion

On April 7th, Curaleaf Holdings (CSE: CURA) announced that they completed $312 million acquisition of...

Friday, April 9, 2021, 11:46:00 AM

Raymond James: Villages Farms Worth Upwards Of $27 Following Full Pure Sunfarms Ownership

Today, analyst Rahul Sarugaser from Raymond James sent out a note to investors about Village...

Tuesday, August 25, 2020, 04:25:08 PM